The effects of central cholecystokinin receptor blockade on hypothalamic-pituitary-adrenal and symptomatic responses to overnight withdrawal from alprazolam.
Abelson
J L
JL
University of Michigan Department of Psychiatry, Ann Arbor.
Curtis
G C
GC
Nesse
R
R
Fantone
R
R
Pyke
R E
RE
Bammert-Adams
J
J
D000328:Adult; D000525:Alprazolam / Q000009:adverse effects*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects*; D007211:Indoles / Q000494:pharmacology*; D008536:Meglumine / Q000031:analogs & derivatives* / Q000494:pharmacology; D008875:Middle Aged; D010913:Pituitary-Adrenal System / Q000187:drug effects*; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors*; D013375:Substance Withdrawal Syndrome / Q000378:metabolism*
D007211:Indoles; D011949:Receptors, Cholecystokinin; C065599:PD 134308; D008536:Meglumine; D000525:Alprazolam